For too many people, it's a knee-jerk reaction: Blame the slow U.S. rollout of COVID-19 vaccines on too little central planning by the administration of President Donald Trump. Demand tighter control from the incoming administration of President-elect Joe Biden. Limit the number of vaccination sites! Bring in the military! Put somebody in charge!
But the problem with the rollout of COVID-19 vaccines isn't that no one is in charge.
Far from the remedy, tighter federal control would probably be a disaster. It would only amplify the problem.
By guaranteeing large purchases, the federal government gave manufacturers strong incentives to produce the vaccines. It was a smart move that worked. But now we're experiencing the downside.
Buying up the supplies and bestowing a vaccine monopoly on state governments blocked the normal distribution channels that connect producers with vaccinators.
Getting any product to its final consumer is not simple. Whether you're laying fiber optic cable or delivering packages, the last mile is the tricky, labor-intensive, expensive part. To reach individuals, the system has to go from centralized operations to decentralized ones. That's why we have retailers rather than ordering our toilet paper from Georgia-Pacific, and why those retailers, in turn, often rely on distributors.
"Cutting out the middleman" is a catchy slogan, but intermediaries make the system work.
When the federal government turned state agencies into the country's vaccine distributors, it bypassed the usual supply chains. Doctors and hospitals couldn't get COVID-19 vaccines the way they order other inoculations.